Biologic Use in Asthma: How Treatment Setting, Other Factors, Affect Adherence
In patients with moderate to severe asthma using biologics, how does the treatment setting affect adherence — and what other factors affect adherence rates?
In patients with moderate to severe asthma using biologics, how does the treatment setting affect adherence — and what other factors affect adherence rates?
Recent research shows that in women, hormonal and other changes occurring during their lifecycle affect their asthma incidence and response to treatment.
Food allergy and obesity raise COVID-19 infection risk, but asthma does not, according to an NIH-funded study.
Do the characteristics of asthma in adults differ depending upon whether the individual develops asthma as a child or as a younger/older adult?
Should patients with asthma or COPD have their inhaler regimens switched for nonclinical reasons? A systematic review examined real world evidence on this subject.
Among children with asthma, are inhaled corticosteroids effective in controlling wheezing that is associated with these children’s gut microbiome?
What are the early-life predictors of peanut allergy, and how does peanut allergy relate to asthma severity?
How does consumption of processed food by children with atopy and asthma affect the gut microbiota and disease severity?
Is the level of asthma control achieved by preschoolers following their asthma diagnosis an indicator of their likely long-term asthma outcomes?
How prevalent are psychiatric conditions in people with asthma, what are the risk factors for these conditions in this population?